罗拉匹坦
Rolapitant.
作者信息
Cada Dennis J, Bindler Ross, Baker Danial E
机构信息
Founder and Contributing Editor, The Formulary.
Drug Information Resident, College of Pharmacy, Washington State University Spokane.
出版信息
Hosp Pharm. 2016 Feb;51(2):165-175. doi: 10.1310/hpj5102-165. Epub 2016 Feb 1.
Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with Through the cooperation of publishes selected reviews in this column. For more information about , contact Wolters Kluwer customer service at 866-397-3433. The February 2016 monograph topics are mepolizumab, cobimetinib, glycopyrrolate, indacaterol/glycopyrrolate, and coagulation factor X (human). The Safety MUE is on mepolizumab.
每月，订阅者会收到5至6篇关于新发布或处于3期临床试验后期的药物的详细专题论文。这些专题论文面向药学与治疗学委员会。订阅者还会每月收到1页关于对议程以及药学/护理在职培训有用的药物的摘要专题论文。每月还会提供一份全面的目标药物利用评估/用药评估（DUE/MUE）。订阅后，专题论文会以印刷形式发送，也可在线获取。专题论文可根据机构需求进行定制。现在每月会发布一次药物类别综述，通过与……合作，会在本专栏发表精选综述。如需了解更多关于……信息，请致电866 - 397 - 3433联系威科集团客户服务。2016年2月专题论文主题包括美泊利单抗、考比替尼、格隆溴铵、茚达特罗/格隆溴铵以及凝血因子X（人源）。安全MUE针对美泊利单抗。
Zotero 插件